Smoore Launches Risk-Assessment Lab for EU’s TPD

An industry-leading risk assessment laboratory for compliance of the European Union Tobacco Product Directive (TPD) has been launched by one of China’s largest vapor manufacturers. Shenzhen-based Smoore has become China’s first company capable of providing vaping products with a one-stop TPD risk assessment service, according to a company press release. A division of Smoore’s fundamental research center, the laboratory will be a hub to empower more vaping brands to comply with the safety standards of TPD.

“This laboratory has begun operation in the first half of 2021, and already completed 52 product tests for several world-leading vape brands. As China’s first corporate TPD-compliant risk assessment laboratory, it can generate test reports within 5 working days,” the release states. “Its laboratory equipment is benchmarked against those in world-class analytical testing laboratories, such as Labstat and Enthalpy.”

Smoore’s fundamental research center has developed a comprehensive analytical testing and risk assessment system, covering PMTA non-clinical testing and health risk assessment. Accredited by China National Accreditation Service for Conformity Assessment (CNAS) in 2019, the lab is capable of up to 149 CNAS tests, involving the chemical analysis of e-liquids and aerosols, electrical safety, material safety and battery safety.

With only one e-cigarette approved by the U.S. Food and Drug Administration through the premarket tobacco product application (PMTA) pathway to date, more and more vape brands are aiming for expansion in the European market. Smoore states that the EU is a “relatively friendly regulatory environment and significant market potential.”

“As the industry’s harm reduction and quality benchmark, Smoore complies with its in-house Smoore 3.0 safety standards. Based on the risk assessment guidance of U.S. Environmental Protection Agency and PMTA, Smoore 3.0 covers all of the PMTA vapor safety tests and Harmful and Potentially Harmful Constituents (HPHCs) listed by U.S. FDA,” the release states. “In addition to vapor safety, Smoore 3.0 also involves extractable and leachable substances of medical-grade atomization materials.”

Since FEELM, Smoore’s flagship atomization technology brand, entered the EU market in 2018, Smoore has been in partnership with several leading vape brands in this EU region, including Vuse, HEXA, Innocigs and Alfapod. To date, vaping products loaded with FEELM technologies have been exported to Belgium, Netherlands, Estonia, and Romania, with market leadership in the UK, Germany and France, the release states.